Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Washington Court Hotel

Sep 25, 2013 8:00 AM - Sep 27, 2013 5:00 PM

525 New Jersey Avenue NW, Washington, DC 20001

DIA/FDA Oligonucleotide-based Therapeutics Conference

Session 8 (Nonclinical, CMC, Clinical Development Tracks): Hot Topics

Session Chair(s)

Arthur A. Levin, PhD

Arthur A. Levin, PhD

CSO

Avidity Biosciences , United States

Haw-Jyh  Chiu, PhD

Haw-Jyh Chiu, PhD

Toxicologist, OMPT, Office of New Drugs, DHOT, CDER

FDA, United States

Hot Topics will present cutting-edge information of interest to all three tracks. This year the hot topics will focus on miRNA roles in disease and therapy, and a novel form of crop protection against insects based on ingestion of siRNA. As a whole the presentations will explore rivaling forces governing RNA expression in maintaining, enhancing, and disrupting function.

Speaker(s)

Bryan R. Cullen, PhD

Viruses and Micro RNAs

Bryan R. Cullen, PhD

Duke University Medical Center, United States

James B. Duke Professor, Dept. of Molecular Genetics & Microbiology

Carolyn  Coyne, PhD

The Placental-specific Chromosome 19 miRNA Cluster (C19MC) Exerts Antiviral Effects Against Diverse Viruses

Carolyn Coyne, PhD

University of Pittsburgh, United States

Assistant Professor, Dept. of Microbiology and Molecular Genetics

Gregory R. Heck, PhD

Using RNAi in Food Crops as Pesticides

Gregory R. Heck, PhD

Monsanto Company, United States

Weed Control Platform Lead

Tita  Ritsema

The Chance of a Lifetime: Developing Antisense Oligonucleotide-mediated RNA Modulation as a Cure for Cystic Fibrosis

Tita Ritsema

ProQR Therapeutics B.V., Netherlands

Program Manager

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.